The global cervical total disc replacement (CTDR) device market was valued at US$0.4 bn in 2014 and is expected to reach US$1.7 bn by 2021. The global cervical total disc replacement device market is expected to expand at a 23.10% CAGR between 2015 and 2021 due to factors such as the growing occurrence of chronic diseases, growing demand for advanced CTDR devices, and increasing aging population.
ASCs Sector to Register More CTDR Incidents
The global cervical total disc replacement device market is segmented on the basis of region, end use, and material type. Based on the material type, the global cervical total disc replacement device market is classified into metal on metal (M-o-M) and metal on a biocompatible material (M-o-B). The metal on a biocompatible material sector dominated the global market in 2014. By region, the global cervical total disc replacement device market is divided into North America Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America was the dominant region in 2014 and is predicted to maintain its dominant position in the global cervical total disc replacement device market by 2021.
By end use, the global cervical total disc replacement device market is classified into ASCs and hospitals. The hospitals sector led the global cervical total disc replacement device market in 2014. However, the ASCs sector is expected to grow at a rapid pace by 2021 due to the increased number of cervical disc replacement cases performed in ASCs. There has been a notable rise in the number of people opting for ASCs for their cervical disc replacement surgeries due to their cost-effectiveness and quick discharge.
Innovations in CTDR to Drive Global Market
The introduction of technically advanced cervical total disc replacement devices by the leading players is expected to propel the global cervical total disc replacement device market during the forecast period. Some of the key players in the global cervical total disc replacement device market are Medtronic, plc, Globus Medical, Inc., LDR Holding Corporation, Depuy Synthes (a Johnson & Johnson Company), and NuVasive, Inc.
Get Sample Report: http://www.persistencemarketresearch.com/samples/3775
Earlier this month, Medtronic, plc, announced that the company is happy to see the results of an advanced cervical total disc replacement device that showed better clinical outcomes as well as patient satisfaction than conventional methods. Their CTDR device, Prestige LP Cervical Disc, displayed improved medical outcome as compared to anterior cervical discectomy and fusion (ACDF).
In Medtronic’s portfolio, Prestige LP Disc is ranked third, amongst the clinically proven and tested cervical discs. Prestige LP Disc is a low-profile cervical disc with a ball-through design and has the capacity to move in different motions such as rotation, bending, and translation.
Anterior cervical discectomy and fusion (ACDF) lacked motion, which has been taken care by the Prestige LP(TM) Cervical Disc. The Prestige LP is primarily meant for preserving neck motion at the operated disc level. This device is specifically designed to take care of single-level cervical disc diseases. Matthew Gornet, an orthopedic surgeon at the Orthopedic Center in St. Louis, MO, said that patients who have undergone cervical disc replacement by using Prestige LP device, have maintained motion and are able to live a quality life. Prestige LP patients are able to maintain a 6.9-degree mean angular motion at their treated level.